These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 28188318

  • 1. PURLs: Need an add-on to metformin? Consider this.
    Wyncott D, Lyon C, Mounsey A.
    J Fam Pract; 2017 Jan; 66(1):42-44. PubMed ID: 28188318
    [Abstract] [Full Text] [Related]

  • 2. Effects on Clinical Outcomes of Adding Dipeptidyl Peptidase-4 Inhibitors Versus Sulfonylureas to Metformin Therapy in Patients With Type 2 Diabetes Mellitus.
    Ou SM, Shih CJ, Chao PW, Chu H, Kuo SC, Lee YJ, Wang SJ, Yang CY, Lin CC, Chen TJ, Tarng DC, Li SY, Chen YT.
    Ann Intern Med; 2015 Nov 03; 163(9):663-72. PubMed ID: 26457538
    [Abstract] [Full Text] [Related]

  • 3. Complementing insulin therapy to achieve glycemic control.
    Barnett AH.
    Adv Ther; 2013 Jun 03; 30(6):557-76. PubMed ID: 23797471
    [Abstract] [Full Text] [Related]

  • 4. Cost-effectiveness analysis of metformin+dipeptidyl peptidase-4 inhibitors compared to metformin+sulfonylureas for treatment of type 2 diabetes.
    Kwon CS, Seoane-Vazquez E, Rodriguez-Monguio R.
    BMC Health Serv Res; 2018 Feb 01; 18(1):78. PubMed ID: 29391064
    [Abstract] [Full Text] [Related]

  • 5. Comparative risk of major cardiovascular events associated with second-line antidiabetic treatments: a retrospective cohort study using UK primary care data linked to hospitalization and mortality records.
    Zghebi SS, Steinke DT, Rutter MK, Emsley RA, Ashcroft DM.
    Diabetes Obes Metab; 2016 Sep 01; 18(9):916-24. PubMed ID: 27177784
    [Abstract] [Full Text] [Related]

  • 6. Metformin combined with dipeptidyl peptidase-4 inhibitors or metformin combined with sulfonylureas in patients with type 2 diabetes: A real world analysis of the South Korean national cohort.
    Cho YY, Cho SI.
    Metabolism; 2018 Aug 01; 85():14-22. PubMed ID: 29530797
    [Abstract] [Full Text] [Related]

  • 7. Safety and efficacy of dipeptidyl peptidase-4 inhibitors vs sulfonylurea in metformin-based combination therapy for type 2 diabetes mellitus: Systematic review and meta-analysis.
    Foroutan N, Muratov S, Levine M.
    Clin Invest Med; 2016 Apr 02; 39(2):E48-62. PubMed ID: 27040861
    [Abstract] [Full Text] [Related]

  • 8. Early glycaemic control in metformin users receiving their first add-on therapy: a population-based study of 4,734 people with type 2 diabetes.
    Thomsen RW, Baggesen LM, Søgaard M, Pedersen L, Nørrelund H, Buhl ES, Haase CL, Johnsen SP.
    Diabetologia; 2015 Oct 02; 58(10):2247-53. PubMed ID: 26277380
    [Abstract] [Full Text] [Related]

  • 9. Real-life efficacy and safety of vildagliptin compared with sulfonylureas as add-on to metformin in patients with type 2 diabetes mellitus in Germany.
    Göke R, Gruenberger JB, Bader G, Dworak M.
    Curr Med Res Opin; 2014 May 02; 30(5):785-9. PubMed ID: 24328429
    [Abstract] [Full Text] [Related]

  • 10. Are sulfonylureas less desirable than DPP-4 inhibitors as add-on to metformin in the treatment of type 2 diabetes?
    Ahrén B.
    Curr Diab Rep; 2011 Apr 02; 11(2):83-90. PubMed ID: 21243448
    [Abstract] [Full Text] [Related]

  • 11. Diabetes: Add-on to metformin in T2DM--linagliptin or glimepiride?
    Christensen M, Knop FK.
    Nat Rev Endocrinol; 2012 Oct 02; 8(10):576-8. PubMed ID: 22926098
    [No Abstract] [Full Text] [Related]

  • 12. Important differences in the durability of glycaemic response among second-line treatment options when added to metformin in type 2 diabetes: a retrospective cohort study.
    Mamza J, Mehta R, Donnelly R, Idris I.
    Ann Med; 2016 Oct 02; 48(4):224-34. PubMed ID: 26982210
    [Abstract] [Full Text] [Related]

  • 13. Comparative risk for cardiovascular diseases of dipeptidyl peptidase-4 inhibitors vs. sulfonylureas in combination with metformin: Results of a two-phase study.
    Enders D, Kollhorst B, Engel S, Linder R, Verheyen F, Pigeot I.
    J Diabetes Complications; 2016 Oct 02; 30(7):1339-46. PubMed ID: 27245402
    [Abstract] [Full Text] [Related]

  • 14. Efficacy and safety of the dipeptidyl peptidase-4 inhibitor, sitagliptin, in patients with type 2 diabetes mellitus inadequately controlled on glimepiride alone or on glimepiride and metformin.
    Hermansen K, Kipnes M, Luo E, Fanurik D, Khatami H, Stein P, Sitagliptin Study 035 Group.
    Diabetes Obes Metab; 2007 Sep 02; 9(5):733-45. PubMed ID: 17593236
    [Abstract] [Full Text] [Related]

  • 15. A Sensitivity Analysis to Assess Bias Due to Selecting Subjects Based on Treatment Received.
    Ertefaie A, Small D, Flory J, Hennessy S.
    Epidemiology; 2016 Mar 02; 27(2):e5-7. PubMed ID: 26628427
    [No Abstract] [Full Text] [Related]

  • 16. The combination of DPP-4 inhibitors versus sulfonylureas with metformin after failure of first-line treatment in the risk for major cardiovascular events and death.
    Yu OH, Yin H, Azoulay L.
    Can J Diabetes; 2015 Oct 02; 39(5):383-9. PubMed ID: 25840943
    [Abstract] [Full Text] [Related]

  • 17. Dipeptidyl peptidase-4 inhibitor compared with sulfonylurea in combination with metformin: cardiovascular and renal outcomes in a propensity-matched cohort study.
    Kim KJ, Choi J, Lee J, Bae JH, An JH, Kim HY, Yoo HJ, Seo JA, Kim NH, Choi KM, Baik SH, Kim SG, Kim NH.
    Cardiovasc Diabetol; 2019 Mar 11; 18(1):28. PubMed ID: 30857540
    [Abstract] [Full Text] [Related]

  • 18. Incorporating New Medications in Diabetes Care.
    Comi RJ.
    Ann Intern Med; 2015 Nov 03; 163(9):719-20. PubMed ID: 26458033
    [No Abstract] [Full Text] [Related]

  • 19. Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients.
    Wang F, He Y, Zhang R, Zeng Q, Zhao X.
    Medicine (Baltimore); 2017 Sep 03; 96(36):e7638. PubMed ID: 28885325
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.